Clinical Trial Update: An Exploratory Study on Efficacy and Safety of Fosaprepitant and Palonosetron Hydrochloride for Injection in Preventing CINV From Multi-Agent HEC [Phase 4]

View source ↗

Summary

Phase 4 exploratory trial evaluating the efficacy and safety of combining fosaprepitant and palonosetron hydrochloride to prevent chemotherapy-induced nausea an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• FOSAPREPITANT (FOSAPREPITANT DIMEGLUMINE)
• Palonosetron hydrochloride (Palonosetron hydrochloride)

Snippet

Sponsor: Shanghai 6th People's Hospital | Conditions: Chemotherapy-induced Nausea and Vomiting | Phase 4 | Status: NOT_YET_RECRUITING